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Maternal Coxsackievirus B Induced Dysregulation of SUMOylation Processes 
as a Potential Cause of Hypoplastic Left Heart Syndrome
 Bailey Kemp, Sarah Severson, Dr. Rachel JohnsonDepartment of Science and Mathematics
University of Minnesota Morris, Morris, MN
Coxsackievirus Disrupts SUMO
CHD-Associated Nkx2-5 Mutants with Irregular SUMOylation
Investigating interruption of Nkx2-5 SUMOylation via coxsackievirus 
as a possible cause of HLHS offers a novel avenue to further explore the 
etiology of this birth defect. Not only is SUMO a regulator of Nkx2-5, but it is 
also involved with other transcription factors associated with HLHS, such as 
Notch1. Because of this, SUMO should be explored further as a possible 
component of heart development. As HLHS is fatal without a complex 
three-part surgery, further understanding of possible etiological roots of this 
condition is necessary. Given these conclusions, this hypothesis not only 
introduces a viral infection relatively unexplored as a cause of HLHS, but also 
explores a potential mechanism that may play a role in abnormal heart 
development. Further investigation into this possible mechanism will allow 
heightened understanding of HLHS and contribute to the identification of a 
cause, and in effect, lead to possible preventative solutions or treatment. 
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Hypoplastic Left Heart Syndrome (HLHS) is a 
life-threatening congenital heart defect with unknown etiology. 
Here we hypothesize that HLHS has etiologic roots in maternal 
asymptomatic coxsackievirus B infection. Coxsackievirus has 
been demonstrated to disrupt normal distribution of small 
ubiquitin-like modifiers (SUMO) in the cell. The vital cardiac 
transcription factor, Nkx2-5, has been shown to be dependent on 
SUMOylation for proper function. Specifically, co-localization 
of SUMO and Nkx2.5 has been identified, as well as decreased 
SUMOylation associated with Nkx2-5 mutants. As Nxk2-5 is 
essential for fetal heart development and mutations in the gene 
for this vital transcription factor have been linked to HLHS, 
disruption of the regular SUMOylation patterns of Nkx2-5 may 
have severe consequences on cardiac development. Considering 
this evidence, we propose a novel mechanism for the underlying 
cause of HLHS. Specifically, we propose that asymptomatic 
maternal coxsackievirus infection crosses the placental barrier 
and  disrupts SUMOylation processes during fetal development.  
This, in turn alters the function of Nkx2-5, ultimately leading to 
underdevelopment of the fetal heart and cardiac anomalies such 
as Hypoplastic Left Heart Syndrome. 
Abstract
We hypothesize that a maternal asymptomatic 
coxsackievirus B infection causes alteration of SUMOylation 
patterns in the fetus, which results in functional repression of the 
transcription factor Nkx2-5, leading to underdevelopment of the 
fetal heart and ultimately Hypoplastic Left Heart Syndrome. 
Hypothesis
Nkx2-5 is a homeobox transcription factor demonstrated to be essential for 
normal cardiac development, as it is one of the beginning factors of a large 
transcriptional cascade, including cardiomyocyte and chamber identity, as well as 
asymmetry of the heart [9]. Due to its role in cardiac development, Nkx2-5 
mutations have been associated with multiple congenital heart diseases, as well as 
directly identified in patients with HLHS [6, 11].
One mechanism by which Nkx2-5 regulation occurs is via small 
ubiquitin-like modifiers (SUMO). [7]. Specifically, SUMO-1 binds to target 
proteins as part of an enzymatic cascade similar to that of ubiquitin. In the context 
of heart development, SUMO has been identified as a key regulator, as both 
SUMO-1 and SUMO-2  mRNA have been found in the developing heart tube, 
chamber myocardium and the cardiac genes it targets. Additionally, SUMO has 
been found to be directly associated with Nkx2-5. For example, Costa et al. 
performed a western blot to reveal Nkx2-5 and SUMO cofactors, as well as an 
immunoprecipitation with Nkx2-5 and SUMO-1 resulting in Nkx2-5 SUMOylated 
bands and SUMOylated Nkx2-5 cofactors. Similarly, an immunohistochemistry 
revealed co-localization of Nkx2-5 and SUMO-1 in embryonic secondary heart 
fields. Specifically, Lysine 51 of Nkx2-5 was confirmed as a site of SUMOylation 
[7].  
Furthermore, Nkx2.5 has been identified to be dependent on SUMO, rather 
than merely co-localized. For example, several mutated variants of human Nkx2-5 
previously associated with CHD’s were identified to have a 50-80% decrease in 
SUMOylation [12]. In mouse models, SUMOylation-deficient Nkx2-5 mutants 
caused multiple cardiac anomalies [12]. While the relationship between SUMO and 
Nkx2-5 is not fully defined, it is clear that alteration of the SUMOylation processes 
could contribute to decreased Nkx2-5 transcriptional activity. 
A potential cause for an interruption of SUMOylation is proposed to be 
coxsackievirus B due to its association with SUMO disruption. In a study conducted 
by Gomes et. al., SUMO-1 was found to be heavily redistributed in coxsackievirus 
infected cells as opposed to controls [8]. While SUMO usually aggregates around 
the nucleus in non-infected cells, coxsackievirus infection has been shown to cause 
significant dispersion of SUMO around the cell. The enzyme UBC9, which is 
necessary for SUMO-1 conjugation, was also found to be redistributed from the 
normal aggregation patterns [8]. As coxsackie virus  can cross the placental barrier 
and transplacentally affect the developing fetus, it can result in disrupted 
SUMOylation in the fetus [14]. As described above, SUMOylation plays a vital role 
in the proper function of Nkx2-5. Therefore, the alteration of SUMO-1 and its 
related enzymes caused by coxsackievirus infection may play a significant role in 
the development of HLHS.
Rationale
SUMO/Nkx2-5 Co-Localization
Figure 3: Coxsackievirus disrupts SUMO
SUMO-1 is normally aggregated around the nucleus. Upon 
coxsackievirus B5 infection, SUMO-1 disperses throughout the cell. 
The cells were stained via immunofluorescence (left) and DAPI (right). 
Gomes R., Guerra-Sa R., and Arruda E. 2010. Coxsackievirus B5 induced apoptosis 
of HeLa cells: Effects on p53 and SUMO. Virology. 396: 256-263.
Hypoplastic Left Heart Syndrome (HLHS) is characterized by 
moderate to severe underdevelopment of the left side of the heart and the 
aorta, and is estimated to affect about 960 infants born in the United states 
every year. While several genetic and environmental components have 
been identified as potential factors in the development of this birth defect, 
the underlying cause of HLHS is still unknown [1].
Viral infections during pregnancy can cause various birth defects. 
Coxsackieviruses, classified as single-stranded RNA enteroviruses, have 
been linked to heart defects, mostly through case studies. Many infections 
are asymptomatic and can often go completely undetected [3]. While there 
is evidence that maternal coxsackievirus infection during pregnancy can 
cross the placental barrier and lead to fetal infection, little is known about 
the viral and cellular mechanisms that may play a role in the etiology of 
fetal heart anomalies.
To propose a possible mechanism by which coxsackievirus 
infection can lead to HLHS, we consider the evidence that HLHS is 
associated with mutations in the gene for the cardiac transcription factor 
Nkx2-5. This evolutionarily-conserved gene is vital for development of the 
heart, and has been linked to several congenital heart defects [6]. There is 
evidence that the function of Nkx2-5 is dependent on modification by small 
ubiquitin-like modifiers (SUMO), and thus, proper SUMOylation processes 
are essential for normal fetal heart development [7]. There is also evidence 
that coxsackievirus infection causes changes in the usual aggregation 
patterns of SUMO-1 and the related enzymes involved in SUMOylation 
[8]. Combining this information, we suggest that an early-term maternal 
coxsackievirus B infection represses the function of Nkx2-5 via 
dysregulation of SUMO.
Background
Figure 2: CHD-associated Nkx2-5 mutants display irregular SUMO modifications
Luciferase activity assays were performed on Hela cell lysates expressing wt Nkx2-5 or Nkx2-5 mutants associated with congenital heart diseases (CHDs). 
In wt Nkx2-5 and multiple mutants, SUMO-1 is demonstrated to facilitate Nkx2-5 activity.
Kim EY, Chen L, Ma Y, Yu W, Chang J, Moskowitz IP, et al. 2011. Expression of Sumoylation Deficient Nkx2.5 Mutant in Nkx2.5 Haploinsufficient Mice Leads to Congenital Heart 
Defects. PLoS ONE. 6(6): e20803. https://doi.org/10.1371/journal.pone.0020803
Figure 1: SUMO/Nkx2-5 Co-localization
Immunohistochemistry of E9.5 embryos show SUMO-1 and SUMO-2 
expressed broadly. This expression of SUMOylation overlaps with regions 
that show Nkx2-5 expression as well. These regions are from the Second 
Heart Field (SHF), including the outflow tract (oft) and lateral mesoderm 
(lm). This exemplifies co-localization of SUMO and Nkx2-5 within the 
heart, suggesting interaction between the two. 
Costa MW, Lee S, Furtado MB, Xin L, Sparrow DB, et al. 2011. Complex SUMO-1 
Regulation of Cardiac Transcription Factor Nkx2-5. PLoS ONE 6(9):
e24812. doi:10.1371/journal.pone.0024812 While coxsackievirus infection during pregnancy has been associated 
with several birth defects such as neurodevelopment delays and early-onset 
diabetes mellitus, to our knowledge the effect of this virus on HLHS etiology 
has not been directly studied. However, there have been several case studies 
published that suggest a possible link between coxsackievirus infection and 
heart defects. Our hypothesis not only provides a possible innovative 
underlying cause - maternal viral infection - but also provides the possible 
mechanisms by which this infection affects heart development: dysregulation 
of SUMOylation of the vital transcription factor, Nkx2-5. While Nkx2-5 has 
been previously linked to HLHS, SUMOylation, as a source of epigenetic 
regulation, has not been explored in the context of HLHS. By providing a 
mechanism for the cause of this birth defect via coxsackievirus and 
disruption of SUMOylation, this hypothesis offers an innovative approach 
that has not yet been explored in the context of HLHS. 
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